First COVID-19 vaccine found to be safe, able to generate rapid immune response in...
Reviewed by Emily Henderson, B.Sc.May 22 2020
The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans,...
Polycistronic delivery of IL-10 and NT-3 to enhance spinal cord injury repair
Reviewed by Emily Henderson, B.Sc.Apr 18 2020
Spinal cord injury (SCI) creates a complex microenvironment that is not conducive to repair; growth factors are in short supply, whereas factors that inhibit regeneration are plentiful. In...
Creso Pharma’s Technological Breakthrough Set To Expand Human Health Cannabis Product Line
By BioChannel - February 10th 2020 566
By Jonathan Jackson
Creso Pharma Limited (ASX:CPH), the ASX-listed, Swiss-based innovative medical cannabis product developer, has started 2020 strongly as...
Perth Biotech Increases Sanitiser Shipment Amid Virus Outbreak
Merlin Chew of The West Australian Monday, 10 February 2020 2:30PM
Holista Colltech chief executive Dr Rajen M with the NatShield Sanitizer. Credit: Supplied
Zoono at Cutting Edge of Reducing Risk of African Swine Flu Outbreaks
Paul Hislop, CEO and majority shareholder of ASX listed ZOONO Group Ltd (ZNO) confirmed at their AGM held in Sydney on 7th November 2109 that Zoono was at that cutting edge of...
